Methyl 2-[(1R,2R,3S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-1,2-dimethylcyclopentyl]acetate
C17H34O4Si — CID 56593895
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[(1R,2R,3S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-1,2-dimethylcyclopentyl]acetate
Methyl 2-[(1R,2R,3S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-1,2-dimethylcyclopentyl]acetate (PubChem CID 56593895) has the molecular formula C17H34O4Si and a molecular weight of 330.54 g/mol. Its IUPAC name is methyl 2-[(1R,2R,3S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-1,2-dimethylcyclopentyl]acetate.
Molecular Properties
| Compound Name | Methyl 2-[(1R,2R,3S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-1,2-dimethylcyclopentyl]acetate |
|---|---|
| PubChem CID | 56593895 |
| Molecular Formula | C17H34O4Si |
| Molecular Weight | 330.54 g/mol |
| Exact Mass | 330.22 |
| IUPAC Name | methyl 2-[(1R,2R,3S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-hydroxy-1,2-dimethylcyclopentyl]acetate |
| SMILES | COC(=O)C[C@@]1(C)CC[C@H](O)[C@@]1(C)CO[Si](C)(C)C(C)(C)C |
| InChI | InChI=1S/C17H34O4Si/c1-15(2,3)22(7,8)21-12-17(5)13(18)9-10-16(17,4)11-14(19)20-6/h13,18H,9-12H2,1-8H3/t13-,16+,17+/m0/s1 |
| InChIKey | MACVWKHOOQMAIQ-IAOVAPTHSA-N |
| XLogP | 3.74 |
| TPSA | 55.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 330.54 |
| LogP ≤ 5 | 3.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 56593895 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.